Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019

SELL
$1.25 - $3.14 $27,500 - $69,080
-22,000 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$2.79 - $4.09 $13,950 - $20,450
5,000 Added 29.41%
22,000 $65,000
Q4 2018

Feb 14, 2019

BUY
$3.23 - $7.01 $22,610 - $49,070
7,000 Added 70.0%
17,000 $57,000
Q2 2018

Aug 13, 2018

BUY
$2.88 - $8.67 $28,800 - $86,700
10,000 New
10,000 $69,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $838M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.